EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)

Yumin Wang, Joshua S Fleishman, Yulin Li, Yuwei Cao, Haidong Wei, Zhe Zhang, Jichao Chen, Mingchao Ding

International Journal of Oncology · 09.12.2024 · 66 (1)

DOI: 10.3892/ijo.2024.5714 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 09.12.2024. Verfasst von Yumin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100…. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Non-Small-Cell Lung, Epigenesis, Genetic, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a novel form of regulated cell death that plays a key role in inhibiting tumor malignancy. The ferroptosis signalling cascade provides new opportunities for lung cancer therapy. Non‑coding RNA (ncRNA)‑mediated epigenetic modification can influence the vulnerability of cancer cells to ferroptosis in non‑small‑cell lung cancer (NSCLC). The present review describes the core molecular mechanisms underlying ferroptosis and the role of epigenetic mechanisms in regulating ferroptosis in NSCLC, as well as developments in understanding the ncRNA‑induced mechanisms that affect ferroptosis in NSCLC. The present review aimed to enhance understanding of the epigenetic mechanisms mediated by ncRNAs that modulate ferroptosis in NSCLC, highlighting a novel therapeutic strategy for NSCLC via the ncRNA‑ferroptosis axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, Non-Small-Cell LungEpigenesis, GeneticLung NeoplasmsRNA, UntranslatedGene Expression Regulation, NeoplasticHumansSignal Transduction

Stichwörter der Autor:innen

ferroptosislung cancernon‑coding RNAnon‑small cell lung cancer

Substanzen

RNA, Untranslated

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, P.R. China.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY 11439, USA.
  • Department of Emergency, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, P.R. China.
  • Department of Peripheral Vascular Intervention, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, Beijing 100049, P.R. China.

Zitieren

APA

Wang, Y., Fleishman, J. S., Li, Y., Cao, Y., Wei, H., Zhang, Z., Chen, J., & Ding, M. (2024). Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review). International Journal of Oncology, 66(1). https://doi.org/10.3892/ijo.2024.5714

Vancouver

Wang Y, Fleishman JS, Li Y, Cao Y, Wei H, Zhang Z, et al. Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review). International Journal of Oncology. 2024;66(1). doi:10.3892/ijo.2024.5714

BibTeX
@article{Wang2024,
  author = {Wang, Yumin and Fleishman, Joshua S and Li, Yulin and Cao, Yuwei and Wei, Haidong and Zhang, Zhe and Chen, Jichao and Ding, Mingchao},
  title = {Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)},
  journal = {International Journal of Oncology},
  year = {2024},
  volume = {66},
  number = {1},
  doi = {10.3892/ijo.2024.5714}
}
Kostenlos starten →